Literature DB >> 19919771

Community vs. facility-based directly observed treatment for tuberculosis in Tanzania's Kilimanjaro Region.

J van den Boogaard1, R Lyimo, C F Irongo, M J Boeree, H Schaalma, R E Aarnoutse, G S Kibiki.   

Abstract

SETTING: Kilimanjaro Region, northern Tanzania.
OBJECTIVE: To assess the effect of the introduction of the patient-centred tuberculosis treatment (PCT) approach-which allows tuberculosis (TB) patients to choose between community and facility-based directly observed treatment (DOT)-on treatment outcomes, and to analyse factors that contribute to opting for community DOT.
DESIGN: Retrospective analysis of treatment outcomes of TB patients registered in the Kilimanjaro Region in 2007, differentiating between patients under community vs. facility-based DOT and taking into account demographic factors, disease classification, TB diagnosis and human immunodeficiency virus (HIV) status.
RESULTS: Data from 2769 TB patients were analysed. Treatment success rates were respectively 81% and 70% in patients under community vs. facility-based DOT (P < 0.001). Cure rates were respectively 73% and 72% in smear-positive pulmonary TB patients under community vs. facility-based DOT (P = 0.62). Women, children, patients residing in districts other than Hai, patients with newly diagnosed TB and patients with smear-negative pulmonary TB were most likely to be under community DOT.
CONCLUSION: The PCT approach was shown to be effective in terms of treatment outcomes. Treatment success rates were higher in patients who opted for community DOT than in patients who chose facility-based DOT (all cases), and were similar in smear-positive pulmonary TB patients under community or facility-based DOT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919771

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  23 in total

1.  Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.

Authors:  Neeraj Dhar; John D McKinney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

2.  New diagnostics for tuberculosis: fulfilling patient needs first.

Authors:  Jean-François Lemaire; Martina Casenghi
Journal:  J Int AIDS Soc       Date:  2010-10-25       Impact factor: 5.396

3.  Children's roles in tuberculosis treatment regimes: constructing childhood and kinship in urban Zambia.

Authors:  Jean Hunleth
Journal:  Med Anthropol Q       Date:  2013-06-26

4.  Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study.

Authors:  Jossy van den Boogaard; Ramsey A Lyimo; Martin J Boeree; Gibson S Kibiki; Rob E Aarnoutse
Journal:  Bull World Health Organ       Date:  2011-05-20       Impact factor: 9.408

5.  Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia.

Authors:  Gebretsadik Berhe; Fikre Enquselassie; Abraham Aseffa
Journal:  BMC Public Health       Date:  2012-07-23       Impact factor: 3.295

6.  Risk factors for non-cure among new sputum smear positive tuberculosis patients treated in tuberculosis dispensaries in Yunnan, China.

Authors:  Hua Jianzhao; Susan van den Hof; Xu Lin; Qiu Yubang; Hou Jinglong; Marieke J van der Werf
Journal:  BMC Health Serv Res       Date:  2011-05-11       Impact factor: 2.655

7.  Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia.

Authors:  Gebrehiwet Tesfahuneygn; Girmay Medhin; Mengistu Legesse
Journal:  BMC Res Notes       Date:  2015-09-29

8.  Community-based directly observed therapy (DOT) versus clinic DOT for tuberculosis: a systematic review and meta-analysis of comparative effectiveness.

Authors:  Cameron M Wright; Lenna Westerkamp; Sarah Korver; Claudia C Dobler
Journal:  BMC Infect Dis       Date:  2015-05-08       Impact factor: 3.090

9.  Facility-based directly observed therapy (DOT) for tuberculosis during COVID-19: A community perspective.

Authors:  Alexandra J Zimmer; Petra Heitkamp; James Malar; Cintia Dantas; Kate O'Brien; Aakriti Pandita; Robyn C Waite
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-06-25

10.  Social economic factors and malaria transmission in Lower Moshi, northern Tanzania.

Authors:  Asanterabi Lowassa; Humphrey D Mazigo; Aneth M Mahande; Beda J Mwang'onde; Shandala Msangi; Michael J Mahande; Epiphania E Kimaro; Eliapenda Elisante; Eliningaya J Kweka
Journal:  Parasit Vectors       Date:  2012-06-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.